Comparison of clinical effect of montelukast and ketotifen in the treatment of children with cough variant asthma
10.3760/cma.j.issn.1008-6706.2015.23.021
- VernacularTitle:孟鲁司特钠与酮替酚治疗小儿咳嗽变异性哮喘效果比较
- Author:
Peilin XU
;
Haihua CHEN
- Publication Type:Journal Article
- Keywords:
Asthma;
Montelukast;
Ketotifen
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;(23):3585-3587
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical effect of montelukast sodium and ketotifen in the treatment of children with cough variant asthma,thus to provide theoretical basis for clinical treatment.Methods 61 children with cough variant asthma were randomly divided into control group and observation group according to the digital table method,31 cases in each group.Patients of two groups were all given antispasmodic and antitussive.The control group was given ketotifen tablets drug therapy,1mg/time,2 times/d,and the observation group was treated with montelukast chewable tablets,5mg/time,1 time /d.After 8 weeks of treatment,the clinical effects were compared between the two groups.Results The total effective rate of the observation group (96.77%)was higher than that of the control group (77.42%),and the difference was statistically significant (χ2 =16.65,P <0.05).The clinical symptoms improved time of the observation group was (5.78 ±1.36)d,which was shorter than (8.45 ±2.24)d of the control group,the difference was statistically significant (t =2.71,P <0.05).The recurrence rate of the observation group (6.45%) was lower than the control group (16.13%),the difference was statistically significant (χ2 =4.67,P <0.05 ). Recurrence time of the observation group was better than that of the control group,the difference was statistically significant (t =7.98,P <0.05 ).Conclusion The curative effect of montelukast special chewing tablets in the treatment of children with bronchial asthma is obviously superior to ketotifen,has less adverse reactions.It was worthy of clinical application.
